Tag: in vitro

June 17, 2018

5 Top Weekly NASDAQ Tech Stocks: AGM Holdings Up 175 Percent

Which NASDAQ tech stocks gained the most last week? AGM Holdings, Nano Dimension, CLPS, Net Element and Foresight Autonomous Holdings...
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
June 3, 2018

5 Top Weekly NASDAQ Tech Stocks: Index Steers Ahead

Which NASDAQ tech stocks gained the most last week? Netlist, ACMR Research, The Meet Group, Quicklogic and MySize Inc took...
May 22, 2018

10 Top 3D Printing Companies

It's expected that the 3D Printing market will be worth over $30 billion by 2022. Here, the Investing News Network...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 9, 2018

OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update

OpGen (NASDAQ:OPGN) today reported financial and operating results for the three months ended March 31, 2018, and provided a summary...
April 29, 2018

5 Top Weekly NASDAQ Tech Stocks: Index Dip Continues

SemiLEDs, AGM Group Holdings, Brightcove, Kingtone Wirelessinfo Solution Holding and Foresight Autonomous Holdings were the top gainers last week.
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 22, 2018

5 Top Weekly NASDAQ Tech Stocks: Index Dip Continues

Which NASDAQ tech stocks gained the most last week? Mattersight, RealNetworks, Meet Group, Iteris and Computer Task Group were the...
April 17, 2018

CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018

CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the presentation of...